Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net income (loss)	$ (10,012)	$ (1,350)
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Investment related (gains) losses on sale of investments and other assets	10,589	(7,277)
Net deferred policy acquisition cost	1,532	1,502
Amortization of cost of customer relationships acquired	775	959
Depreciation	413	954
Amortization of premiums and discounts on investments	3,456	4,065
Stock-based compensation	300	406
Deferred federal income tax expense (benefit)	150	(370)
Change in:
Accrued investment income	(418)	512
Reinsurance recoverable	2,054	(7,971)
Due premiums	197	1,940
Future policy benefit reserves	22,920	22,292
Other policyholders' liabilities	1,104	20,668
Federal income tax receivable	1,231	1,855
Commissions payable and other liabilities	6,367	(14,342)
Other, net	(895)	(73)
Net cash provided by (used in) operating activities	39,763	23,770
Cash flows from investing activities:
Purchases of fixed maturity securities, available-for-sale	(102,348)	(62,809)
Sales of fixed maturity securities, available-for-sale	30,348	8,238
Maturities and calls of fixed maturity securities, available-for-sale	37,890	40,395
Principal payments on mortgage loans	1,097	7
Funding of mortgage loans	0	(1,000)
(Increase) decrease in policy loans, net	2,222	3,216
Sales of other long-term investments	4,130	20,893
Purchases of other long-term investments	(18,150)	(27,514)
Sales of property and equipment	0	14
Purchase of property and equipment	(76)	(847)
Purchase of short-term investments	(1,250)	0
Net cash provided by (used in) investing activities	(46,137)	(19,407)
Cash flows from financing activities:
Annuity deposits	6,777	6,901
Annuity withdrawals	(6,634)	(5,855)
Acquisition of treasury stock	(2,183)	(9,090)
Issuance of common stock	2,244	0
Other	(117)	(363)
Net cash provided by (used in) financing activities	87	(8,407)
Net increase (decrease) in cash and cash equivalents	(6,287)	(4,044)
Cash and cash equivalents at beginning of year	27,294	34,131
Cash and cash equivalents at end of period	$ 21,007	$ 30,087